Global Pneumococcal Vaccine Market Research Report 2021
- Published Date: 2021-01-29
- Report ID: 49010
- Pages: 150
-
Format:
Prudent Markets Predicts that Pneumococcal Vaccine Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Pneumococcal Vaccine Market Overview:
Global Pneumococcal Vaccine Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Pneumococcal Vaccine involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Pneumococcal Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Pneumococcal Vaccine market in 2020.
Global Pneumococcal Vaccine Market Segmentation
By Type, Pneumococcal Vaccine market has been segmented into:
PCV13
PPSV23
By Application, Pneumococcal Vaccine market has been segmented into:
Infants and Children younger than 2 Years Old
Children 2 through 5 Years Old
Children 6 through 18 Years Old
Adults 19 years or older
Adults 65 years or older
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Pneumococcal Vaccine market are:
MSD
Sanofipasteur
Pfizer
GSK
1. Market Overview of Pneumococcal Vaccine
1.1 Pneumococcal Vaccine Market Overview
1.1.1 Pneumococcal Vaccine Product Scope
1.1.2 Market Status and Outlook
1.2 Pneumococcal Vaccine Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Pneumococcal Vaccine Historic Market Size by Regions (2015-2020)
1.4 Pneumococcal Vaccine Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Pneumococcal Vaccine Sales Market by Type (2015-2026)
2.1 Global Pneumococcal Vaccine Historic Market Size by Type (2015-2020)
2.2 Global Pneumococcal Vaccine Forecasted Market Size by Type (2021-2026)
2.3 PCV13
2.4 PPSV23
3. Covid-19 Impact Pneumococcal Vaccine Sales Market by Application (2015-2026)
3.1 Global Pneumococcal Vaccine Historic Market Size by Application (2015-2020)
3.2 Global Pneumococcal Vaccine Forecasted Market Size by Application (2021-2026)
3.3 Infants and Children younger than 2 Years Old
3.4 Children 2 through 5 Years Old
3.5 Children 6 through 18 Years Old
3.6 Adults 19 years or older
3.7 Adults 65 years or older
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Pneumococcal Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Pneumococcal Vaccine Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Pneumococcal Vaccine Business
5.1 MSD
5.1.1 MSD Company Profile
5.1.2 MSD Pneumococcal Vaccine Product Specification
5.1.3 MSD Pneumococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Sanofipasteur
5.2.1 Sanofipasteur Company Profile
5.2.2 Sanofipasteur Pneumococcal Vaccine Product Specification
5.2.3 Sanofipasteur Pneumococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Pfizer
5.3.1 Pfizer Company Profile
5.3.2 Pfizer Pneumococcal Vaccine Product Specification
5.3.3 Pfizer Pneumococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 GSK
5.4.1 GSK Company Profile
5.4.2 GSK Pneumococcal Vaccine Product Specification
5.4.3 GSK Pneumococcal Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Pneumococcal Vaccine Market Size (2015-2026)
6.2 North America Pneumococcal Vaccine Key Players in North America (2015-2020)
6.3 North America Pneumococcal Vaccine Market Size by Type (2015-2020)
6.4 North America Pneumococcal Vaccine Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Pneumococcal Vaccine Market Size (2015-2026)
7.2 East Asia Pneumococcal Vaccine Key Players in North America (2015-2020)
7.3 East Asia Pneumococcal Vaccine Market Size by Type (2015-2020)
7.4 East Asia Pneumococcal Vaccine Market Size by Application (2015-2020)
8. Europe
8.1 Europe Pneumococcal Vaccine Market Size (2015-2026)
8.2 Europe Pneumococcal Vaccine Key Players in North America (2015-2020)
8.3 Europe Pneumococcal Vaccine Market Size by Type (2015-2020)
8.4 Europe Pneumococcal Vaccine Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Pneumococcal Vaccine Market Size (2015-2026)
9.2 South Asia Pneumococcal Vaccine Key Players in North America (2015-2020)
9.3 South Asia Pneumococcal Vaccine Market Size by Type (2015-2020)
9.4 South Asia Pneumococcal Vaccine Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Pneumococcal Vaccine Market Size (2015-2026)
10.2 Southeast Asia Pneumococcal Vaccine Key Players in North America (2015-2020)
10.3 Southeast Asia Pneumococcal Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumococcal Vaccine Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Pneumococcal Vaccine Market Size (2015-2026)
11.2 Middle East Pneumococcal Vaccine Key Players in North America (2015-2020)
11.3 Middle East Pneumococcal Vaccine Market Size by Type (2015-2020)
11.4 Middle East Pneumococcal Vaccine Market Size by Application (2015-2020)
12. Africa
12.1 Africa Pneumococcal Vaccine Market Size (2015-2026)
12.2 Africa Pneumococcal Vaccine Key Players in North America (2015-2020)
12.3 Africa Pneumococcal Vaccine Market Size by Type (2015-2020)
12.4 Africa Pneumococcal Vaccine Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Pneumococcal Vaccine Market Size (2015-2026)
13.2 Oceania Pneumococcal Vaccine Key Players in North America (2015-2020)
13.3 Oceania Pneumococcal Vaccine Market Size by Type (2015-2020)
13.4 Oceania Pneumococcal Vaccine Market Size by Application (2015-2020)
14. South America
14.1 South America Pneumococcal Vaccine Market Size (2015-2026)
14.2 South America Pneumococcal Vaccine Key Players in North America (2015-2020)
14.3 South America Pneumococcal Vaccine Market Size by Type (2015-2020)
14.4 South America Pneumococcal Vaccine Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Pneumococcal Vaccine Market Size (2015-2026)
15.2 Rest of the World Pneumococcal Vaccine Key Players in North America (2015-2020)
15.3 Rest of the World Pneumococcal Vaccine Market Size by Type (2015-2020)
15.4 Rest of the World Pneumococcal Vaccine Market Size by Application (2015-2020)
16 Pneumococcal Vaccine Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
